Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

March 27, 2017

Primary Completion Date

January 31, 2019

Study Completion Date

March 31, 2019

Conditions
Acne Vulgaris Superficial Mixed Comedonal and Inflammatory
Interventions
COMBINATION_PRODUCT

PDF+M-DDO

Participants with moderate and severe acne will be treated two times a day on the face and superior back with a smooth layer (standard finger tip unit 0.5 g for an area of 100 to 120 square centimeters) of Zaxcell (Pirfenidone with M-DDO) in form of a gel. Patients have to wait 20 min without cover those sites.

COMBINATION_PRODUCT

A+PBO

Participants with moderate and severe acne will be treated once a day (at night) on the face and superior back with a smooth layer (standard finger tip unit 0.5 g for an area of 100 to 120 square centimeters) of Effezel (Adapalene with benzoyl peroxide) in form of a gel. Patients have to wait 20 min without cover those sites

Trial Locations (1)

44280

Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hospital Civil de Guadalajara

OTHER

collaborator

Cell Pharma

OTHER

lead

University of Guadalajara

OTHER